Efficacy and safety of roflumilast foam 0.3% in patients with seborrheic dermatitis in a randomized, double-blind, vehicle-controlled phase 2 study

被引:0
|
作者
Zirwas, Matthew [1 ,2 ]
Draelos, Zoe D. [3 ]
DuBois, Janet [4 ]
Kircik, Leon [5 ]
Moore, Angela [6 ]
Gold, Linda Stein [7 ]
Higham, Robert C. [8 ]
Navale, Lynn [8 ]
Burnett, Patrick [8 ]
Berk, David R. [8 ]
机构
[1] Prob Med Res, Dermatologists Cent States, Waterloo, ON, Canada
[2] Ohio State Univ, Columbus, OH 43210 USA
[3] Dermatol Consulting Serv, High Point, NC USA
[4] DermResearch Inc, High Point, NC USA
[5] Icahn Sch Med Mt Sinai, Indiana Med Ctr, Phys Skin Care PLLC & Skin Sci PLLC, New York, NY 10029 USA
[6] Arlington Ctr Dermatol, Arlington, TX USA
[7] Henry Ford Med Ctr, Detroit, MI USA
[8] Arcutis Biotherapeut Inc, Westlake Village, CA USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
28588
引用
收藏
页码:AB47 / AB47
页数:1
相关论文
共 50 条